NDC Package 10135-581-10 Triamterene And Hydrochlorothiazide

View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

10135-581-10

Package Description:

1000 CAPSULE in 1 BOTTLE

Product Code:

10135-581

Proprietary Name:

Triamterene And Hydrochlorothiazide

Usage Information:

This fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked.Triamterene and hydrochlorothiazide capsules, USP are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone.Triamterene and hydrochlorothiazide capsules, USP are also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked.Triamterene and hydrochlorothiazide capsules, USP may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. Since triamterene and hydrochlorothiazide capsules, USP may enhance the action of these agents, dosage adjustments may be necessary.Usage in Pregnancy: The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia.Edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. Diuretics are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy. Dependent edema in pregnancy resulting from restriction of venous return by the expanded uterus is properly treated through elevation of the lower extremities and use of support hose; use of diuretics to lower intravascular volume in this case is illogical and unnecessary. There is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother (in the absence of cardiovascular disease), but which is associated with edema, including generalized edema in the majority of pregnant women. If this edema produces discomfort, increased recumbency will often provide relief. In rare instances this edema may cause extreme discomfort which is not relieved by rest. In these cases a short course of diuretics may provide relief and may be appropriate.

11-Digit NDC Billing Format:

10135058110

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

1000 EA

NDC to RxNorm Crosswalk:

RxCUI: 198316 - hydroCHLOROthiazide 25 MG / triamterene 37.5 MG Oral Capsule

RxCUI: 198316 - hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule

RxCUI: 198316 - HCTZ 25 MG / triamterene 37.5 MG Oral Capsule

Labeler Name:

Marlex Pharmaceuticals Inc

Sample Package:

Start Marketing Date:

10-01-2014

Listing Expiration Date:

12-31-2020

Exclude Flag:

Code Structure:

10135 - Marlex Pharmaceuticals Inc
- 10135-581 - Triamterene And Hydrochlorothiazide
  - 10135-581-10 - 1000 CAPSULE in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
10135-581-01	100 CAPSULE in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 10135-581-10?

The NDC Packaged Code 10135-581-10 is assigned to a package of 1000 capsule in 1 bottle of Triamterene And Hydrochlorothiazide, labeled by Marlex Pharmaceuticals Inc. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1000 billable units per package.

Is NDC 10135-581 included in the NDC Directory?

No, Triamterene And Hydrochlorothiazide with product code 10135-581 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Marlex Pharmaceuticals Inc on October 01, 2014 and its listing in the NDC Directory is set to expire on December 31, 2020 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 10135-581-10?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1000.

What is the 11-digit format for NDC 10135-581-10?

The 11-digit format is 10135058110. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	10135-581-10	5-4-2	10135-0581-10

Table of Contents